NextCure Inc. (NXTC) PT Lowered at Piper Sandler Following the Reverse Stock Split
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff lowered the price target on NextCure Inc. (NASDAQ: NXTC) to $15.00 (from $36.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
